This blog is related to the various litigations related to patents w.r.t pharma industry.
Tuesday, August 4, 2009
Elan Drug Technologies Announces First Approval of a Long Acting Injectable Formulation Using NanoCrystal Technology
Aug 3, 2009 - Elan Drug Technologies, a business unit of Elan Corporation, plc announces the first approval of a long-acting injectable formulation using Elan Drug Technologies' proprietary NanoCrystal® technology.
No comments:
Post a Comment